NCT04417842View on ClinicalTrials.gov

Connect Lung Outcomes With Bronchodilator Use

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

April 25, 2022

Study Completion Date

April 25, 2022

Conditions
Chronic Obstructive Pulmonary DiseaseAsthma
Interventions
DIAGNOSTIC_TEST

Respimetrix flow-volume monitoring device

The Respimetrix flow-volume monitoring device is being tested to validate its ability to measure Inspiratory Capacity

Trial Locations (1)

21286

Pulmonary and Critical Care Associates Of Baltimore, Towson

All Listed Sponsors
lead

Pulmonary Critical Care Associates of Baltimore

OTHER

NCT04417842 - Connect Lung Outcomes With Bronchodilator Use | Biotech Hunter | Biotech Hunter